Bogle Grant C. 4
4 · Epizyme, Inc. · Filed Jun 15, 2021
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Bogle Grant C.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-11+40,559→ 40,559 totalExercise: $8.53Exp: 2031-06-10→ Common Stock (40,559 underlying) - Award
Common Stock, par value $0.0001
2021-06-11+8,060→ 8,060 total
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 8,060 restricted stock units ("RSUs") granted on June 11, 2021, which RSUs are scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. Each RSU represents the right to receive one share of Common Stock upon vesting. In the event of a change in control of the Issuer, the RSUs will vest in full.
- [F2]This option was granted on June 11, 2021 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full.